Search for: "ALLERGAN, INC." Results 121 - 140 of 384
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jul 2008, 10:41 am
The maker of the drug, Allergan Inc. is the company, and the company is based in Califoria. [read post]
10 May 2011, 3:40 pm by Kristine Meredith
 A jury agreed, ordering Allergan Inc. to pay to Ray $12 million in compensatory damages and $200 million in punitive damages. [read post]
15 Apr 2019, 9:23 pm by Patent Docs
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc.... [read post]
31 Mar 2015, 9:59 pm by Patent Docs
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Lupin Ltd., Lupin Pharmaceuticals, and Hi-Tech Pharmacal in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug gatifloxacin as claimed in re-examined U.S. [read post]
19 Dec 2017, 9:59 pm by Patent Docs
But today, an expanded panel of the Board, including Chief Judge David Ruschke, issued an order dismissing a sovereign immunity challenge by the State of Minnesota in Ericsson Inc. and Telefonaktiebolaget LM Ericsson v. [read post]
11 Feb 2008, 8:19 am
Public Citizen asked U.S. authorities to require the strongest possible warning, highlighted in a "black box," on Allergan Inc's Botox and Solstice Neuroscience Inc's Myobloc. [read post]
14 Dec 2011, 6:38 am by Neil Rosenbaum
., here and here) to eight California surgical centers and one marketing firm for misleading advertising of Allergan Inc. [read post]
19 Aug 2013, 3:52 pm by Anubha Sinha
 Further, the respondent also failed to disclose to the controller the information required by Section 8 of the Act, in particular, the European counterpart of the subject Patent- which was not granted by the EPO.The applicant also cited the US  Court of Appeals judgment in respect of the US counterpart of the impugned patent Allergan Inc vs. [read post]
5 Aug 2008, 4:54 am
Voet, Senior Vice President and Chief Intellectual Property Counsel at Allergan, Inc., has published the second addition of his helpful primer, "The Generic Challenge: Understanding Patents, FDA & Pharmaceutical Life-Cycle Management" (Brown Walker Press: Boca Raton, FL; 183 pp., $28.95). [read post]
19 May 2011, 9:12 pm
Teleflex, Inc., 550 U.S. 398, 421 (2007). [read post]
21 Mar 2015, 6:26 am by Lawrence B. Ebert
Reference IPR2015-00858.Although  this claim survived litigation challenge in Allergan, Inc. v. [read post]
5 May 2011, 4:39 pm by Robert Elliott, J.D.
The complaint accused Allergan Inc., the manufacturer, of failing to warn about the risk of brain damage from Botox triggering an autoimmune reaction. [read post]
24 May 2011, 6:12 pm by Lawrence B. Ebert
Pfizer, Inc., 233 P.3d 1066 (Cal. 2010), make clear that section 17204 only requires that a party allege an injury in fact and that the injury was caused by the defendant. [read post]